Komori
Sugi Holdings (7649) · RiskReframed

Risk of economic and earnings impacts from COVID-19

First written in FY2020. 11 of 14 entries say "Materialised", first in FY2021-Q1. Latest entry: FY2025.

14entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2021-Q1 – FY2024-Q2RestatedFY2025-Q12020: 320202021: 420212022: 220222023: 320232024: 120242025: 12025
Same theme, other companies
Risk of COVID-19 impacts on business activities, supply chains, demand and financial performanceA theme 1257 companies write about · 1269 as a headwind · 6 as a tailwind

The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1283 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025ReframedAnnual report

    「The pandemic and stagnation of economic activity」

    It has been reorganised from descriptions of specific impacts related to COVID-19 into a general business continuity risk relating to natural disasters, pandemics and other events.
  2. FY2025-Q1RestatedAnnual report

    「Declining sales of products related to COVID-19 as the pandemic subsided」

    It continues to describe declining sales of products related to COVID-19 as the pandemic subsided as an actual impact on the business environment.
  3. FY2024-Q2MaterialisedAnnual report

    「Declining sales of products related to COVID-19 as the pandemic subsided」

    Declining sales of products related to COVID-19 as the pandemic subsided continued to affect the business environment during the period.
  4. FY2024-Q1MaterialisedAnnual report

    「The operating environment surrounding the Group has become increasingly difficult due to declines in prescription prices caused by revisions to drug prices and certain dispensing fees, lower sales of COVID-related products as the pandemic subsided, and intensifying competition among companies from other industries and peers as the number of stores increased.」

    It states that declining sales of products related to COVID-19 as the pandemic subsided were an actual impact on the business environment.
  5. FY2023MaterialisedAnnual report

    「During the current consolidated fiscal year (1 March 2022 to 28 February 2023), Japan’s economy showed signs of recovery in socioeconomic activity despite the continued impact of COVID-19, due to the easing of restrictions on activities and border-control measures.」

    It describes both the continued impact of COVID-19 throughout the fiscal year and signs of a recovery in economic activity following the easing of activity restrictions and border-control measures.
  6. FY2023-Q2MaterialisedAnnual report

    「Although demand for some products increased due to the renewed spread of COVID-19 and record heat, the operating environment surrounding the industry has become increasingly difficult due to the substantial reductions in drug prices and certain dispensing fees implemented in April, sluggish growth in prescriptions filled as infections spread again, and further intensification of competition to open stores.」

    It states that the resurgence of COVID-19 infections was actually affecting the business environment during the period, including through sluggish growth in prescription fulfilment.
  7. FY2022-Q3MaterialisedAnnual report

    「During the cumulative third quarter of the current consolidated fiscal year, Japan’s economy remained in a difficult situation due to the impact of COVID-19. However, the number of new cases declined substantially in Japan against the backdrop of a high vaccination rate, and moves toward normalising economic activity through the easing of restrictions began to emerge. Nevertheless, concerns over another resurgence of COVID-19 infections and rising costs, including raw material prices, have become apparent, and the outlook for the economy remains uncertain.」

    It states that, while the impact of the pandemic continues, moves toward normalising economic activity coexist with concerns over another resurgence, and rising costs have also become apparent.
  8. FY2022-Q2MaterialisedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year (1 March 2021 to 31 August 2021), Japan’s economy remained affected by sluggish personal consumption and continued restrictions on corporate activity amid the resurgence of COVID-19 infections.」

    It states that sluggish personal consumption and restrictions on corporate activity caused by the resurgence of COVID-19 infections were actually present in the economic environment during the period.
  9. FY2022-Q1MaterialisedAnnual report

    「Demand, particularly personal consumption, declined as the renewed spread of COVID-19 led to the application of priority preventive measures to the affected regions and the issuance of a third state of emergency.」

    The company states that the renewed spread of COVID-19 and measures including states of emergency actually led to a decline in demand for personal consumption.
  10. FY2021MaterialisedAnnual report

    「Against the backdrop of the spread of COVID-19, demand increased for infection-prevention products such as masks and disinfectant alcohol, as well as stay-at-home products such as food and household goods. At the same time, demand for cosmetics weakened as lifestyles changed, including the promotion of telework; inbound demand disappeared due to entry restrictions; and the number of cold and influenza patients fell sharply as mask-wearing, handwashing, and disinfectant use became habitual.」

    The company states that the impact of the pandemic actually materialized as increased demand for infection-prevention and stay-at-home products, weak demand for cosmetics, the disappearance of inbound demand, and a decline in the number of cold and influenza patients.
  11. FY2021-Q3MaterialisedAnnual report

    「The spread of COVID-19 led to declines in corporate earnings and personal consumption and deterioration in the employment environment, resulting in challenging conditions. The outlook also remains extremely uncertain, as the number of COVID-19 patients has again begun to trend upward.」

    The company describes the impact of the spread of COVID-19 on corporate earnings, personal consumption, and the employment environment, as well as uncertainty about the outlook due to the renewed increase in patient numbers, as the actual economic environment.
  12. FY2021-Q2MaterialisedAnnual report

    「A decline in the number of prescriptions dispensed due to reduced medical consultations against the backdrop of the spread of COVID-19, and a prolonged slump in inbound demand due to entry restrictions, among other factors」

    The company states that the impact of COVID-19 continues to be seen in an actual decline in the number of prescriptions dispensed and a prolonged slump in inbound demand.
  13. FY2021-Q1MaterialisedAnnual report

    「In the drugstore industry, demand increased for some products, such as masks, as well as for daily necessities and food, resulting in more store visits. However, the operating environment surrounding the Group remains precarious due to a sharp decline in inbound demand caused by restrictions on cross-border travel and a decline in the number of patients visiting stores for prescription dispensing as fewer people visited medical institutions.」

    The company states that COVID-19 has had specific effects, including inbound demand and a decline in the number of patients visiting stores for prescription dispensing.
  14. FY2020First statedAnnual report

    「In response to COVID-19, we established a task force and thoroughly implemented infection-control measures, including installing ethanol disinfectant, promoting ventilation, conducting regular cleaning and disinfection, taking employees’ temperatures before work, and installing splash-prevention panels at stores. To support the customers and patients of local communities, all employees are prioritizing the continuation of store operations. The impact on our group is limited at present, but if the situation becomes more serious or prolonged, it may affect our business performance.」

    Against the backdrop of the global spread of COVID-19, the company describes the current impact as limited while identifying the potential impact on business performance if the situation becomes more serious or prolonged as a new risk.
Moved together

"Drug-price cuts, intensifying competition and slower sales of temporary-demand products" moved the same way as this thread, in the same document, in 12 of its 14 moves.

12108322★123456
  1. ★This thread
  2. 1Drug-price cuts, intensifying competition and slower sales of temporary-demand products12×
  3. 2Risk of impairment of store fixed assets due to intensifying competition and changes in trading areas10×
  4. 3A stronger yen, falling share prices and uncertainty over the outlook for personal consumption8×
  5. 4Continued Increases in Labor and Construction Costs3×
  6. 5Qualitative transformation of the business structure, systems and operating model2×
  7. 6Rebuilding personnel systems for diverse and productive work styles2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Sugi Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of economic and earnings impacts from COVID-19 | SUGI HOLDINGS Co.,LTD. (7649) | Komori